You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in Branded Drug GOOD NEIGHBOR PHARMACY CHILDRENS IBUPROFEN


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for Good Neighbor Pharmacy Children’s Ibuprofen

Last updated: March 5, 2026

What is the excipient composition for Good Neighbor Pharmacy Children’s Ibuprofen?

Good Neighbor Pharmacy Children’s Ibuprofen typically contains active and inactive ingredients as follows:

  • Active ingredient: 100 mg or 200 mg of ibuprofen per 5 mL dose.
  • Inactive ingredients (excipients): These often include:
    • Sucrose, for flavor and sweetness.
    • High fructose corn syrup (HFCS), as a sweetener.
    • Citric acid, for pH adjustment.
    • Artificial colors (e.g., FD&C Blue No. 1).
    • Flavors (e.g., cherry or grape).
    • Preservatives (e.g., sodium benzoate).

The use of sucrose and HFCS sustains a sweet taste profile, leading to higher adherence among children but raises concerns over sugar content. Artificial colors and flavors target consumer acceptance but face regulatory scrutiny.

How does excipient composition influence formulation strategies?

Formulation choices influence stability, palatability, safety, and regulatory compliance:

  • Sweeteners: Sucrose and HFCS improve taste but contribute to high sugar content, which may conflict with current health guidelines aimed at reducing sugar intake.
  • Colors and flavors: Enhance acceptability but require regulatory approval and considerations for allergenic potential (e.g., sensitivities to artificial colorings).
  • Preservatives: Ensure microbiological stability but are increasingly scrutinized for safety and allergenic potential.

Formulators must balance organoleptic qualities (taste, appearance) with safety and regulatory trends favoring reduced sugar and artificial additives.

What are the commercial opportunities related to excipient choices?

Supply chain optimization, formulation innovation, and regulatory positioning offer multiple avenues:

1. Sugar-Free and Reduced-Sugar Variants

Growing consumer demand for lower-sugar options creates opportunities:

  • Use of alternative sweeteners (e.g., sucralose, stevia) reduces calorie content.
  • Potential to differentiate via "sugar-free" branding in pediatric analgesics.

2. Natural Coloring and Flavors

Shift toward natural extracts (e.g., beet juice, turmeric for colors) aligns with clean-label trends:

  • Satisfies regulatory pressure to eliminate synthetic dyes.
  • Appeals to health-conscious consumers.

3. Preservative-Free or Alternative Preservation

Development of preservative-free formulations or natural preservatives (e.g., vitamin E derivatives):

  • Addresses safety concerns related to synthetic preservatives.
  • Offers a competitive advantage in a regulatory environment favoring natural ingredients.

4. Regulatory and Patent Opportunities

  • Patents for novel excipient combinations or delivery mechanisms may extend market exclusivity.
  • Regulatory approval pathways for reformulated products can open new market segments.

5. Manufacturing and Supply Chain Impact

  • Securing reliable sources for natural or alternative excipients supports product differentiation.
  • Investment in formulation capabilities for reformulations can position manufacturers ahead of regulatory or consumer trends.

What are key market trends affecting excipient strategy?

  • Regulatory tightening: Agencies like FDA and EMA scrutinize excipients with potential safety concerns, especially in pediatric populations.
  • Consumer preference: Shift toward natural, minimally processed ingredients.
  • Health trends: Movement away from added sugars and artificial colors.
  • Innovation focus: Emphasis on taste-masking and stability with alternative excipients.

How do excipient choices impact regulatory approval and market access?

  • Use of compliant excipients simplifies approval pathways.
  • Novel excipients require safety data and regulatory submission.
  • Labeling claims (e.g., "sugar-free," "natural colors") depend on ingredient chemistry and regulatory approval.

Summary table of excipient considerations

Aspect Current Use Trends Opportunities
Sweeteners Sucrose, HFCS Reduced sugar, alternatives Natural, zero-calorie sweeteners
Colors Artificial dyes Natural, plant-based Beet juice, turmeric derivatives
Flavors Synthetic, fruit flavors Natural extracts Organic, clean-label flavorings
Preservatives Sodium benzoate Preservative-free, natural options Preservation technologies using antioxidants

Key considerations for formulation development

  • Prioritize consumer safety and regulatory compliance.
  • Innovate with natural, healthier excipients.
  • Balance palatability with sugar reduction efforts.
  • Position products to meet evolving market preferences.

Key Takeaways

  • Excipient strategies for children’s ibuprofen emphasize taste, safety, and regulatory compliance.
  • Sugar content remains a significant challenge; alternatives like artificial or natural sweeteners offer growth opportunities.
  • Moving toward natural colors and flavors improves market positioning amid regulatory and consumer pressures.
  • Patent opportunities exist in novel excipient combinations and delivery mechanisms.
  • Clear regulatory pathways depend on excipient safety profiles and ingredient transparency.

FAQs

1. What excipients are safest for pediatric OTC medications?
Excipients like xylitol, sorbitol, and natural flavorings are generally considered safe when used within approved limits. However, avoid excipients with known allergenic or irritant potential unless specifically approved.

2. Can artificial colors be replaced with natural alternatives?
Yes, natural color sources such as beet juice, turmeric, and spirulina can replace synthetic dyes and are increasingly popular due to regulatory and consumer preferences.

3. How does sugar reduction affect formulation stability?
Reducing or eliminating sucrose or HFCS may impact taste and preservative efficacy. Reformulation often requires alternative sweeteners and preservative strategies to maintain stability and palatability.

4. Are there regulatory challenges with new excipients or natural ingredients?
Yes. Natural ingredients and novel excipients require safety data and validation processes. Regulatory filings may be complex depending on the ingredient's history and intended usage.

5. What strategic steps can manufacturers take to capitalize on excipient trends?
Invest in R&D for sugar-free, clean-label formulations. Build supply chains for natural excipients. Pursue patent protection for unique formulations, and align marketing with health-conscious consumer trends.


References

[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: Color Additives and Color Additive Exceptions for Drug Use.
[2] European Medicines Agency. (2021). Pediatric Medicines: Added considerations for excipient safety.
[3] Market Research Future. (2022). Pediatric OTC Analgesics Market Report.
[4] GlobalData. (2022). Excipient Trends in OTC Pediatric Formulations.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.